$45.98 1.9%
BMY Stock Price vs. AI Score
Data gathered: July 30

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

AI Stock Analysis - Bristol-Myers Squibb (BMY)

Analysis generated November 29, 2024. Powered by Chat GPT.

Bristol Myers Squibb (BMY) is a globally recognized biopharmaceutical company. It focuses on discovering, developing, and delivering innovative medicines that help patients overcome serious diseases. The company is known for its robust pipeline of potential products and a strong portfolio of existing therapies catering to oncology, cardiovascular, immunoscience, and fibrotic diseases.

Read full AI stock Analysis

Stock Alerts - Bristol-Myers Squibb (BMY)

company logo Bristol-Myers Squibb | July 30
Business Outlook among employees is down by 4.7% over the last month.
company logo Bristol-Myers Squibb | July 14
Job postings are down by 19.6% in the last couple of days.
company logo Bristol-Myers Squibb | July 7
Job postings are down by 18.6% in the last couple of days.
company logo Bristol-Myers Squibb | July 4
Virginia Foxx (member of U.S. congress) is selling shares

Download our app to get future alerts delivered in real-time.

About Bristol-Myers Squibb

The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.


Bristol-Myers Squibb
Price $45.98
Target Price Sign up
Volume 13,930,000
Market Cap $95.4B
Year Range $43.54 - $61.6
Dividend Yield 5.14%
PE Ratio 17.49
Analyst Rating 33% buy
Earnings Date July 31 '25
Industry Drug Manufacturers

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '2511.2B3.03B8.17B2.46B4.48B1.800
Q4 '2412.3B7.26B5.08B72M2.55B1.670
Q3 '2411.9B5.28B6.62B1.21B4.77B1.800
Q2 '2412.2B3.27B8.93B1.68B4.4B2.070
Q1 '2411.9B2.93B8.93B-11.9B-8.56B-4.400

Insider Transactions View All

Hirawat Samit filed to buy 83,513 shares at $47.6.
April 29 '25
BOERNER CHRISTOPHER S. filed to buy 104,626 shares at $55.
February 21 '25
Hirawat Samit filed to buy 63,932 shares at $54.8.
February 19 '25
Holzer Phil M filed to sell 11,760 shares at $55.6.
November 5 '24

Congress Trading View All

Politician Filing Date Type Size
Virginia Foxx
Jul 4, 25 Sell $1K - $15K
Jefferson Shreve
Jun 23, 25 Sell $15K - $50K
Julie Johnson
May 15, 25 Sell $1K - $15K

What is the Market Cap of Bristol-Myers Squibb?

The Market Cap of Bristol-Myers Squibb is $95.4B.

What is Bristol-Myers Squibb's PE Ratio?

As of today, Bristol-Myers Squibb's PE (Price to Earnings) ratio is 17.49.

When does Bristol-Myers Squibb report earnings?

Bristol-Myers Squibb will report its next earnings on July 31 '25.

What is the current stock price of Bristol-Myers Squibb?

Currently, the price of one share of Bristol-Myers Squibb stock is $45.98.

How can I analyze the BMY stock price chart for investment decisions?

The BMY stock price chart above provides a comprehensive visual representation of Bristol-Myers Squibb's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Bristol-Myers Squibb shares. Our platform offers an up-to-date BMY stock price chart, along with technical data analysis and alternative data insights.

Does BMY offer dividends to its shareholders?

Yes, Bristol-Myers Squibb (BMY) offers dividends to its shareholders, with a dividend yield of 5.14%. This dividend yield represents Bristol-Myers Squibb's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Bristol-Myers Squibb in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.

What are some of the similar stocks of Bristol-Myers Squibb?

Some of the similar stocks of Bristol-Myers Squibb are Johnson & Johnson, Eli Lilly and Company, Pfizer, Astrazeneca, and AbbVie.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2025 AltIndex. All rights reserved.

Chat with AltIndex AI

👋 Welcome to AltIndex AI Chat!

Ask about:
  • Top Stocks
  • AI score insights
  • Trending investment opportunities
  • How to use AltIndex
You need to log in to use AltIndex AI Chat.
Disclaimer: AI outputs may be incorrect. This is for informational purposes only and not a substitute for professional financial advice.